Aavis Pharmaceuticals
USFDA-approved manufacturer of specialty generic medications founded in 2015 and based in Hoschton, Georgia.
USFDA-approved manufacturer of specialty generic medications founded in 2015 and based in Hoschton, Georgia.
Aavis Pharmaceuticals is a USFDA-approved manufacturer of specialty generic medications founded in 2015 and based in Hoschton, Georgia. The company is engaged in Contract Development and Manufacturing of Generic Pharmaceuticals. Aavis Pharmaceuticals has positioned itself as one of the fastest-growing pharmaceutical companies in the Atlanta Region, USA.
They are focused on developing niche generic drugs with expertise in advanced scientific research, process development, patent analysis, regulatory compliance, and market & competition analysis. With a commitment to continuous improvement in manufacturing processes, technology, and possible vertical integration, Aavis is aiming to be a market leader in the generics they develop.
The company's last investment of $600.00K came from a Venture Round investment on 24 October 2017. The investors behind this round are not disclosed.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $600.00K | - | 24 Oct 2017 | |
| Venture Round | $1.88M | - | 10 Aug 2015 |
No recent news or press coverage available for Aavis Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.